Skip to main content
Journal of Basic and Clinical Pharmacy logoLink to Journal of Basic and Clinical Pharmacy
. 2012 May 15;3(2):261–264. doi: 10.4103/0976-0105.103818

Lycopene: Redress for Prostate Cancer

Sai Venkata Vedavyas Pisipati 1,*, Harshavardhan Pathapati 1, Ganesh Bhukya 1, Suresh Nuthakki 1, Baburao Chandu 1, SreeKanth Nama 1, RajDev Adeps 1
PMCID: PMC3979252  PMID: 24826034

Abstract

Lycopene, a carotenoid is what that gives red colour to some fruits like pomegranate, tomato, papaya etc... People with a sound diet of lycopene may have a less risk of cancers especially prostate cancer which is most impedent for the males of age 40-50 years. So, in countries of north America and Europe food contains much of the lycopene supplements. In accordance with the American journal of epidemiology 2002 studies implies that men with crushed serum lycopene levels are more divulged to prostate cancer and those with sound diet of lycopene have a less risk of prostate cancer. In a care study conveyed by The British journal of urology, men with prostate cancer are subjected to surgery and the tumour is detonated. Amongst the men half a set were supplemented with lycopene supplements and half were not. Those subjected with lycopene supplements have less bone pains and live longer than those not supplemented. This paints a picture about importance of lycopene in treatment of prostate cancer. This article evokes the importance of lycopene and its way of destroying the cancer. Lycopene reduces the risk of cancer by diverging its effect on the plasma Insulin like growth factor, on Connexins , and the most acceptable one, by quench of free radicals.

KEY WORDS: Lycopene, Insulin like growth factor, Anti oxidant, conjugated bonds, Prostate cancer, Connexins

Full Text

The Full Text of this article is available as a PDF (842.5 KB).


Articles from Journal of Basic and Clinical Pharmacy are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES